Ding 2019.

Study name	Evaluation of an innovative mobile health programme for the self management of chronic obstructive pulmonary disease (MH‐COPD): protocol of a randomised controlled trial
Methods	Study design: open, parallel, randomised controlled trial in Australia Duration: 23 weeks Setting: secondary care
Participants	Population: 100 adults targeted for inclusion Inclusion criteria: COPD diagnosis defined by GOLD, chronic airflow limitation that is not fully reversible, current or former smoker Exclusion criteria: pregnant women, under 18, intellectual or mental impairment, other comorbid lung diseases that would potentially interfere with outcomes, limitations to the use of mobile technology
Interventions	Measurements taken at baseline, 3 months, and 6 months. Treatment arms: Acess to smartphone app and secure online clinician portal, training video, self‐management tools that encompass health education, symptom monitoring, electronic action plans, physical activity, smoking cessation, inhaler technique, reminders
Outcomes	Quality of life (CAT, SQRQ, MMRC) Knowledge (Lung Foundation Australia questionnaire on COPD knowledge) Impact on health behavior (TAI questionnaire, smoking cessation, use of COPD action plan) Exacerbations Healthcare utilisation (readmissions and ED visits) Physical activity (GPAQ, step count for intervention group)
Starting date	January 2019 ‐ December 2020
Contact information	Dr Hang Ding, hang.ding@csiro.au
Notes	Funding: The Prince Charles Hospital Foundation Other identifiers: ACTRN12618001091291

CAT: COPD assessment test;COPD: chronic obstructive pulmonary disease;ED: emergency department;GOLD: Global Initiative for Chronic Obstructive Lung Disease; GPAQ: Global Physical Activity Questionnaire; MMRC: Modified Medical Research Council; SGRQ: St: George's Respiratory Questionnaire; TAI: Test of Adherence to Inhalers.